CM
CGEM icon

Caption Management’s Cullinan Oncology CGEM Stock Holding History

Caption Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,800
Closed -$60K – 1615
2025
Q4 		$60K Buy
+5,800
New +$52.3K ﹤0.01% 1460
2024
Q4 		– Sell
-69,900
Closed -$1.17M – 1490
2024
Q3 		$1.17M Buy
+69,900
New +$1.24M 0.02% 732

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Caption Management's CGEM Position: Q4 2025 in Review

Caption Management sold out of Cullinan Oncology (CGEM) in Q4 2025, closing a stake of 28,389 shares — an estimated $256K sold.

Caption Management first reported a position in CGEM in Q3 2024 and held it in 3 quarters. The position peaked at $1.32M in Q2 2025. 153 funds tracked by Wall St. Rank hold CGEM as of Q4 2025.

  • Caption Management reported no remaining Cullinan Oncology position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 28,389 Cullinan Oncology shares in Q4 2025, an estimated $256K.
  • Caption Management first reported a position in Cullinan Oncology in Q3 2024 and held it in 3 quarters.
  • Caption Management's Cullinan Oncology position peaked at $1.32M in Q2 2025.
  • 153 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.